Sign in

CIK 0001551306

  • Large accelerated filer

Progyny, Inc.

Sign in to watch
Ticker
PGNY
Exchange
Nasdaq
Industry
Services-Misc Health & Allied Services, NEC
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272220139
Phone
+1 212-888-3124
Business address
1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
Former names
Auxogyn, Inc., Auxogyn Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$22,674,844
in 10 filings, $22.0M under 10b5-1 plans

Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-01-02 Anevski Peter CHIEF EXECUTIVE OFFICER Shares withheld for taxes −6,009 $25.68 $154K 674,242
2025-12-31 Sturmer Michael E PRESIDENT Shares withheld for taxes −33,028 $25.84 $853K 255,205
2025-12-11 Livingston Mark S. CHIEF FINANCIAL OFFICER Sale 10b5-1 −459 $25.50 $12K 46,983
2025-12-04 Livingston Mark S. CHIEF FINANCIAL OFFICER Shares withheld for taxes −479 $24.55 $12K 47,442
2025-12-04 Sturmer Michael E PRESIDENT Shares withheld for taxes −7,977 $24.55 $196K 288,233
2025-12-04 Swartz Allison EVP, GC Shares withheld for taxes 10b5-1 −408 $24.55 $10K 73,249
2025-12-04 Swartz Allison EVP, GC Sale 10b5-1 −530 $24.59 $13K 72,719
2025-12-02 Livingston Mark S. CHIEF FINANCIAL OFFICER Shares withheld for taxes 10b5-1 −224 $25.27 $6K 48,134
2025-12-02 Livingston Mark S. CHIEF FINANCIAL OFFICER Sale 10b5-1 −213 $25.50 $5K 47,921
2025-12-02 Sturmer Michael E PRESIDENT Shares withheld for taxes −448 $25.27 $11K 296,210
2025-11-28 Swartz Allison EVP, GC Shares withheld for taxes 10b5-1 −1,352 $26.70 $36K 76,055
2025-11-28 Swartz Allison EVP, GC Sale 10b5-1 −2,398 $26.87 $64K 73,657
2025-11-18 Payson Norman Director Gift −50,265 6,689
2025-11-17 Livingston Mark S. CHIEF FINANCIAL OFFICER Sale 10b5-1 −21,303 $25.50 $543K 48,358
2025-11-14 Payson Norman Director Exercise or conversion +36,224 $1.45 $53K 56,954
2025-11-14 Payson Norman Director Exercise or conversion · Stock Option (Right to Buy) −36,224 0
2025-11-13 Anevski Peter CHIEF EXECUTIVE OFFICER Purchase +79,500 $24.29 $1.9M 680,251
2025-11-10 Schlanger David J Executive Chairman Grant or award +41,500 261,919
2025-11-10 Schlanger David J Executive Chairman Shares withheld for taxes −21,286 $22.37 $476K 240,633
2025-11-10 Anevski Peter CHIEF EXECUTIVE OFFICER Grant or award +125,000 664,564

Page 7 of 51 · 1,002 trades